BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 37371103)

  • 1. HnRNP Pathologies in Frontotemporal Lobar Degeneration.
    Jiang X; Gatt A; Lashley T
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
    Gittings LM; Foti SC; Benson BC; Gami-Patel P; Isaacs AM; Lashley T
    Acta Neuropathol Commun; 2019 Feb; 7(1):18. PubMed ID: 30755280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.
    Snowden JS; Hu Q; Rollinson S; Halliwell N; Robinson A; Davidson YS; Momeni P; Baborie A; Griffiths TD; Jaros E; Perry RH; Richardson A; Pickering-Brown SM; Neary D; Mann DM
    Acta Neuropathol; 2011 Jul; 122(1):99-110. PubMed ID: 21424531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in Semantic Dementia but not with other TDP-43 pathological subtypes of Frontotemporal Lobar Degeneration.
    Davidson YS; Robinson AC; Flood L; Rollinson S; Benson BC; Asi YT; Richardson A; Jones M; Snowden JS; Pickering-Brown S; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Jun; 5(1):54. PubMed ID: 28666471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing.
    Bampton A; Gatt A; Humphrey J; Cappelli S; Bhattacharya D; Foti S; Brown AL; Asi Y; Low YH; Foiani M; Raj T; Buratti E; Fratta P; Lashley T
    Acta Neuropathol; 2021 Oct; 142(4):609-627. PubMed ID: 34274995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
    Seltman RE; Matthews BR
    CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
    Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
    Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of heterogeneous nuclear ribonucleoproteins in frontotemporal lobar degeneration with FUS-positive inclusions.
    Gami-Patel P; Bandopadhyay R; Brelstaff J; Revesz T; Lashley T
    Neurobiol Aging; 2016 Oct; 46():192-203. PubMed ID: 27500866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.
    Davidson YS; Flood L; Robinson AC; Nihei Y; Mori K; Rollinson S; Richardson A; Benson BC; Jones M; Snowden JS; Pickering-Brown S; Haass C; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Apr; 5(1):31. PubMed ID: 28431575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.
    Seelaar H; Klijnsma KY; de Koning I; van der Lugt A; Chiu WZ; Azmani A; Rozemuller AJ; van Swieten JC
    J Neurol; 2010 May; 257(5):747-53. PubMed ID: 19946779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
    A Armstrong R
    Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.
    Hofmann JW; Seeley WW; Huang EJ
    Annu Rev Pathol; 2019 Jan; 14():469-495. PubMed ID: 30355151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
    Urwin H; Josephs KA; Rohrer JD; Mackenzie IR; Neumann M; Authier A; Seelaar H; Van Swieten JC; Brown JM; Johannsen P; Nielsen JE; Holm IE; ; Dickson DW; Rademakers R; Graff-Radford NR; Parisi JE; Petersen RC; Hatanpaa KJ; White CL; Weiner MF; Geser F; Van Deerlin VM; Trojanowski JQ; Miller BL; Seeley WW; van der Zee J; Kumar-Singh S; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bigio EH; Deng HX; Halliday GM; Kril JJ; Munoz DG; Mann DM; Pickering-Brown SM; Doodeman V; Adamson G; Ghazi-Noori S; Fisher EM; Holton JL; Revesz T; Rossor MN; Collinge J; Mead S; Isaacs AM
    Acta Neuropathol; 2010 Jul; 120(1):33-41. PubMed ID: 20490813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.
    Scarioni M; Gami-Patel P; Peeters CFW; de Koning F; Seelaar H; Mol MO; van Swieten JC; ; Rozemuller AJM; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
    Brain; 2023 Jan; 146(1):307-320. PubMed ID: 35136978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of heterogeneous nuclear ribonucleoproteins and survival motor neuron protein in TDP-43 positive inclusions in frontotemporal lobar degeneration.
    Neumann M; Igaz LM; Kwong LK; Nakashima-Yasuda H; Kolb SJ; Dreyfuss G; Kretzschmar HA; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2007 May; 113(5):543-8. PubMed ID: 17415574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal lobar degeneration: diversity of FTLD lesions.
    Seilhean D; Bielle F; Plu I; Duyckaerts C
    Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice.
    Walker AK; Tripathy K; Restrepo CR; Ge G; Xu Y; Kwong LK; Trojanowski JQ; Lee VM
    Hum Mol Genet; 2015 Dec; 24(25):7241-54. PubMed ID: 26476406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
    Lourenco GF; Janitz M; Huang Y; Halliday GM
    Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontotemporal dementia: clinical features, genetics, pathogenesis and treatment].
    Rosenmann H; Meiner Z
    Harefuah; 2013 Nov; 152(11):661-6, 687. PubMed ID: 24416825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signature laminar distributions of pathology in frontotemporal lobar degeneration.
    Ohm DT; Cousins KAQ; Xie SX; Peterson C; McMillan CT; Massimo L; Raskovsky K; Wolk DA; Van Deerlin VM; Elman L; Spindler M; Deik A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol; 2022 Mar; 143(3):363-382. PubMed ID: 34997851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.